Xiaolong Huang, Tao Cheng, Fengkai Xu, Di Ge, Cheng Zhan. Metabolic reprogramming underlying EGFR-TKI resistance in lung cancer. // Biochimica et Biophysica Acta: Molecular Cell Research. – DOI: 10.1016/j.bbamcr.2026.120223. – URL: https://www.sciencedirect.com/science/article/pii/S0167488926001229?dgcid=rss_sd_all
Xiaolong Huang, Tao Cheng, Fengkai Xu, Di Ge, & Cheng Zhan Metabolic reprogramming underlying EGFR-TKI resistance in lung cancer. Biochimica et Biophysica Acta: Molecular Cell Research. https://doi.org/10.1016/j.bbamcr.2026.120223
Xiaolong Huang, et al. “Metabolic reprogramming underlying EGFR-TKI resistance in lung cancer.” Biochimica et Biophysica Acta: Molecular Cell Research. doi:10.1016/j.bbamcr.2026.120223.
@article{Huang,
title = {Metabolic reprogramming underlying EGFR-TKI resistance in lung cancer},
author = {Huang, Xiaolong and Cheng, Tao and Xu, Fengkai and Ge, Di and Zhan, Cheng},
journal = {Biochimica et Biophysica Acta: Molecular Cell Research},
doi = {10.1016/j.bbamcr.2026.120223},
url = {https://www.sciencedirect.com/science/article/pii/S0167488926001229?dgcid=rss_sd_all}
}